Publicacions en què col·labora amb Laura Sánchez-Tejada (5)

2013

  1. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: A potential target treatment

    Human Pathology, Vol. 44, Núm. 2, pp. 218-225

2012

  1. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

    British Journal of Cancer, Vol. 106, Núm. 8, pp. 1367-1373

2011

  1. Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma

    Modern Pathology, Vol. 24, Núm. 2, pp. 201-208

2010

  1. Papel de "pituitary tumour-transforming gene (PTTG)" en los adenomas hipofisarios

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 57, Núm. 1, pp. 28-34

2009

  1. Low activation of Insulin-like Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma

    Breast Cancer Research and Treatment, Vol. 117, Núm. 2, pp. 433-441